TAK-559
Sponsors
Takeda
Conditions
Diabetes Mellitus
Phase 3
Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
TerminatedNCT00762112
Start: 2003-11-30End: 2004-12-31Updated: 2012-11-12
Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
CompletedNCT00763022
Start: 2003-11-30End: 2004-12-31Updated: 2012-11-12
Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
TerminatedNCT00762684
Start: 2004-11-30End: 2004-12-31Updated: 2012-11-12